Home › Uterine Cancer › Rhode Island › Providence

Uterine Cancer clinical trials in Providence, RI

4 studies for Uterine Cancer are looking for participants at sites in and around Providence (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

RecruitingPhase 4

Women & Infants Hospital of Rhode Island/The Program in Women´s Oncology - Clinic, Providence
Women & Infants Hospital of Rhode Island, Providence
Women & Infant´s Hospital Infusion Center, Providence

Ages 18 and older · Women · Updated Sep 25, 2026 · NCT06952660

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

RecruitingPhase 3

Research Site, Providence

Ages 18 and older · Women · Updated Sep 3, 2026 · NCT06989112

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

RecruitingPhase 1/2

Women and Infants Hospital of Rhode Island, Providence

Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT05579366

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

RecruitingPhase 2

Lifespan Cancer Institute - Rhode Island Hospital, Providence

Ages 8 and older · All sexes · Updated Jul 27, 2026 · NCT05503797

About Uterine Cancer

Uterine cancer is a cancer that forms in tissues of the uterus. It is more likely to happen after menopause. There are things you can do that may help lower your risk.

More about Uterine Cancer on MedlinePlus

Uterine Cancer trials in other cities

Other studies in Providence

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.